Double-blind, Placebo-controlled Study of BGC20-1531 in Migraine
This study has been terminated.
(No patients enrolled. Delay due to optimisation of drug product formulation.)
Sponsor:
BTG Ltd.
Information provided by:
BTG Ltd.
ClinicalTrials.gov Identifier:
NCT00888680
First received: April 27, 2009
Last updated: July 12, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |